Clinical Trials on Prostatic Hyperplasia in Italy

Total 360 results

San Carlo di Nancy Hospital
Elesta S.R.L.

Completed

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy | Benign Prostatic Hypertrophy With Outflow Obstruction | Prostate Hyperplasia

Italy
RECORDATI GROUP

Completed

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (SiRE)

Benign Prostatic Hyperplasia

Italy
Catholic University of the Sacred Heart

Completed

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

Benign Prostatic Hyperplasia (BPH) | Benign Prostatic Enlargement (BPE)

Italy
Threshold Pharmaceuticals
PRA Health Sciences

Terminated

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | Enlarged Prostate

Hungary, Poland, Germany, Italy
University of Bari
Gaetano de Rienzo; Pasquale Ditonno; Francesco Di Modugno; Michele Battaglia; Giuseppe... and other collaborators

Unknown

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

Italy
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
IRCCS Policlinico S. Matteo

Completed

Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (Odyliresin)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction

Italy
Eli Lilly and Company

Completed

A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms

Benign Prostatic Hyperplasia | Enlarged Prostate

United States, Italy, France, Belgium, Mexico, Argentina, Greece, Germany, Canada, Russian Federation, Poland, Turkey, Brazil
University of Rome Tor Vergata

Recruiting

Focal Laser Ablation for Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Italy
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
IRCCS San Raffaele

Recruiting

Protocollo N 2014 - Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Italy
Eli Lilly and Company

Completed

A Study in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Italy, Austria
Azienda Ospedaliero Universitaria Maggiore della...

Recruiting

Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial (ProSeRePEA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Obstruction

Italy
University of Florence
Eli Lilly and Company

Completed

Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

Italy
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United Kingdom, Taiwan, Korea, Republic of, Canada, Slovakia, France, Italy, Austria, Czech Republic, Australia, Germany
Eli Lilly and Company

Completed

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Benign Prostatic Hyperplasia

Italy, United States, Germany, Mexico, Argentina
Boston Scientific Corporation

Completed

Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH

Benign Prostatic Hyperplasia

United Kingdom, Germany, Austria, Spain, Belgium, France, Italy, Netherlands, Switzerland
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
University of Rome Tor Vergata
European Institute of Oncology; Ospedale Regina Apostolorum

Unknown

Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | BPH

Italy
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

Italy, France, Belgium, Australia, Greece, Austria, Netherlands, Germany, Mexico, Poland
Société Internationale d'Urologie

Recruiting

BPH Global Registry

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada, Italy, United Kingdom, Cyprus, United States, Chile
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
University of Florence

Completed

TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST (PROTEST)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia | Hypogonadism

Italy
GlaxoSmithKline

Completed

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Prostatic Hyperplasia | Prostatitis

Italy
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
University of Florence

Completed

Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients

Obesity | Insulin Resistance | Prostatic Hyperplasia | Hypogonadism

Italy
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

Prostatic Hyperplasia

Germany, Russian Federation, Spain, Italy, France
Société Internationale d'Urologie

Active, not recruiting

Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

Turkey, Portugal, Italy, Greece, Spain
Eli Lilly and Company

Completed

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia (COMORBID©)

Benign Prostatic Hyperplasia | Erectile Dysfunction

United States, France, Italy, Greece, Mexico, Portugal, Canada, Germany, Russian Federation
GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (PLUS)

Overactive Bladder | Benign Prostatic Hyperplasia

United States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
Azienda Socio Sanitaria Territoriale degli Spedali...
Takeda

Unknown

PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation. (PRO-EPI)

Intermediate Risk Prostate Cancer | High Risk Prostate Cancer

Italy
Consorzio Oncotech

Unknown

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Prostate Cancer | Castration-resistant Prostate Cancer

Italy
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) (DELUTS)

Lower Urinary Tract Symptoms (LUTS)

United States, Canada, Belgium, Czech Republic, Italy, Poland
Azienda Ospedaliero-Universitaria Careggi

Completed

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer (ANCHISES)

Metastatic Prostate Cancer | Elderly Patients

Italy
National Cancer Institute, Naples

Active, not recruiting

Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.

Metastatic Castration-resistent Prostate Cancer

Italy
IRCCS San Raffaele

Recruiting

Optimizing the Number of Systematic COres During a MRI Target Biopsy

Suspicion of Prostate Cancer With a Positive Multiparametric Magnetic Resonance of the Prostate

Italy
Azienda Ospedaliera Città della Salute e della...
Koelis

Recruiting

Targeted Microwave Focal Therapy

Prostate Cancer Stage I

Italy
AEterna Zentaris

Completed

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

Netherlands, Belarus, Bulgaria, Czech Republic, France, Germany, Italy, Macedonia, The Former Yugoslav Republic of, Romania, United Kingdom
Fondazione del Piemonte per l'Oncologia
National Cancer Institute (NCI); University of Pisa; Royal Marsden NHS Foundation... and other collaborators

Recruiting

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer Aggressiveness

Italy
Nerviano Medical Sciences

Completed

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Metastatic Hormone Refractory Prostate Cancer

Italy
University of Florence
Azienda Ospedaliero-Universitaria Careggi; Istituto per lo Studio, la Prevenzione...

Recruiting

SLPI for Prostate Cancer

Prostate Cancer | Prostatic Neoplasm

Italy
Azienda Ospedaliero-Universitaria Careggi

Recruiting

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (PSICHE)

Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Biochemical Relapse Fo Malignant Neoplasm of Prostate

Italy
University of Roma La Sapienza

Enrolling by invitation

Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I (ProSa-I)

Prostate Cancer (Diagnosis)

Italy
Azienda Ospedaliero-Universitaria di Modena

Recruiting

Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed (PSMA-PROSTAPET)

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Italy
Azienda Ospedaliero-Universitaria Careggi

Not yet recruiting

APalutamiAPalutamide and stEReotactic Body Radiation Therapy for Metastatic Prostate Cancer (PERSIAN)

Oligometastatic Hormone Sensitive Prostate Cancer

Italy

Clinical Trials on Prostatic Hyperplasia in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations